Effect of Theophylline in Pseudohypoparathyroidism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Theophylline in Pseudohypoparathyroidism — Stella

View on ClinicalTrials.gov

Recruiting

Back to PHP Ia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Phase

Post-approval study

Sponsor

Massachusetts General Hospital

Enrollment target

~100 participants

Started

November 2019

Primary completion

April 2030

Age range

5 Years – 21 Years

Last updated July 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.